A Phase I, Open-Label, Multicenter, Dose Escalation and Cohort Expansion Study of SPYK04 as Monotherapy in Patients with Locally Advanced or Metastatic Solid Tumors

Protocol No
CHUGAI-SPK101JG
Phase
I
Summary

This project is being done to test SPYK04 to find out if it is safe and to understand the way the body processes the drug.

Description
A Phase 1 Study of Spyk04 as Monotherapy in Patients with Solid Tumors
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL